Devon K. Taylor

1.3k total citations
18 papers, 948 citations indexed

About

Devon K. Taylor is a scholar working on Immunology, Molecular Biology and Rheumatology. According to data from OpenAlex, Devon K. Taylor has authored 18 papers receiving a total of 948 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 2 papers in Molecular Biology and 2 papers in Rheumatology. Recurrent topics in Devon K. Taylor's work include Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (9 papers) and Immunotherapy and Immune Responses (6 papers). Devon K. Taylor is often cited by papers focused on Immune Cell Function and Interaction (10 papers), T-cell and B-cell Immunology (9 papers) and Immunotherapy and Immune Responses (6 papers). Devon K. Taylor collaborates with scholars based in United States, Canada and Netherlands. Devon K. Taylor's co-authors include Laurence A. Turka, Patrick Walsh, Adeeb Rahman, David C. Neujahr, David F. LaRosa, Robert H. Vonderheide, Dmitry I. Gabrilovich, Rina Kim, Linda Spatz and Krishnan Sundar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

Devon K. Taylor

18 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Devon K. Taylor United States 12 675 157 133 126 101 18 948
Erik H. Rozemuller Netherlands 21 747 1.1× 91 0.6× 165 1.2× 163 1.3× 96 1.0× 66 1.1k
Richard Batchelor United Kingdom 13 694 1.0× 140 0.9× 135 1.0× 96 0.8× 76 0.8× 21 1.2k
Eduard Palou Spain 18 373 0.6× 99 0.6× 209 1.6× 78 0.6× 241 2.4× 53 995
A Svejgaard Denmark 16 411 0.6× 82 0.5× 83 0.6× 117 0.9× 71 0.7× 41 831
Laure Bourdery United States 6 1.6k 2.4× 78 0.5× 132 1.0× 209 1.7× 222 2.2× 7 1.9k
Dário Ligeiro Portugal 17 440 0.7× 107 0.7× 371 2.8× 134 1.1× 90 0.9× 47 895
R Storb United States 17 512 0.8× 77 0.5× 114 0.9× 262 2.1× 91 0.9× 34 1.2k
R.F. Schipper Netherlands 17 871 1.3× 61 0.4× 140 1.1× 172 1.4× 141 1.4× 27 1.3k
Nathalie Brassard Canada 19 612 0.9× 119 0.8× 247 1.9× 77 0.6× 231 2.3× 27 1.2k
Giuliana Cassese Germany 10 1.0k 1.5× 79 0.5× 139 1.0× 198 1.6× 80 0.8× 12 1.3k

Countries citing papers authored by Devon K. Taylor

Since Specialization
Citations

This map shows the geographic impact of Devon K. Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Devon K. Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Devon K. Taylor more than expected).

Fields of papers citing papers by Devon K. Taylor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Devon K. Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Devon K. Taylor. The network helps show where Devon K. Taylor may publish in the future.

Co-authorship network of co-authors of Devon K. Taylor

This figure shows the co-authorship network connecting the top 25 collaborators of Devon K. Taylor. A scholar is included among the top collaborators of Devon K. Taylor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Devon K. Taylor. Devon K. Taylor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kim, Rina, Devon K. Taylor, Robert H. Vonderheide, & Dmitry I. Gabrilovich. (2023). Ferroptosis of immune cells in the tumor microenvironment. Trends in Pharmacological Sciences. 44(8). 542–552. 68 indexed citations
2.
Malhotra, Deepali, Eleanor Clancy‐Thompson, Bilal Omar, et al.. (2022). 469 Preclinical studies support clinical development of AZD2936, a monovalent bispecific humanized antibody targeting PD-1 and TIGIT. Regular and Young Investigator Award Abstracts. A489–A489. 5 indexed citations
3.
Butterfield, Tiffany R., Nicole Brown, Jabari Brown, et al.. (2021). Assessment of commercial SARS-CoV-2 antibody assays, Jamaica. International Journal of Infectious Diseases. 105. 333–336. 5 indexed citations
4.
Smith, Michael A., Jill Hénault, Jodi L. Karnell, et al.. (2019). SLE Plasma Profiling Identifies Unique Signatures of Lupus Nephritis and Discoid Lupus. Scientific Reports. 9(1). 14433–14433. 18 indexed citations
5.
Hernandez-Santana, Yasmina, Devon K. Taylor, Alison A. Humbles, & Patrick Walsh. (2019). Advancing the therapeutic potential of the IL‐1 family in inflammatory diseases – Meeting report. European Journal of Immunology. 49(1). 8–10. 1 indexed citations
6.
Nicholson, Simone M., Gianluca Carlesso, Lily Cheng, et al.. (2017). Effects of ICOS+ T cell depletion via afucosylated monoclonal antibody MEDI-570 on pregnant cynomolgus monkeys and the developing offspring. Reproductive Toxicology. 74. 116–133. 10 indexed citations
7.
Rahman, Adeeb, Devon K. Taylor, & Laurence A. Turka. (2009). The contribution of direct TLR signaling to T cell responses. Immunologic Research. 45(1). 25–36. 114 indexed citations
8.
Rahman, Adeeb, Weiguo Cui, David F. LaRosa, et al.. (2008). MyD88 Plays a Critical T Cell-Intrinsic Role in Supporting CD8 T Cell Expansion during Acute Lymphocytic Choriomeningitis Virus Infection. The Journal of Immunology. 181(6). 3804–3810. 61 indexed citations
9.
LaRosa, David F., Jason S. Stumhofer, Andrew E. Gelman, et al.. (2008). T cell expression of MyD88 is required for resistance toToxoplasma gondii. Proceedings of the National Academy of Sciences. 105(10). 3855–3860. 90 indexed citations
10.
Taylor, Devon K., et al.. (2006). Loss of tolerance of anti-dsDNA B cells in mice overexpressing CD19☆. Molecular Immunology. 43(11). 1776–1790. 11 indexed citations
11.
Taylor, Devon K., Patrick Walsh, David F. LaRosa, et al.. (2006). Constitutive Activation of STAT5 Supersedes the Requirement for Cytokine and TCR Engagement of CD4+ T Cells in Steady-State Homeostasis. The Journal of Immunology. 177(4). 2216–2223. 14 indexed citations
12.
Walsh, Patrick, Devon K. Taylor, & Laurence A. Turka. (2004). Tregs and transplantation tolerance. Journal of Clinical Investigation. 114(10). 1398–1403. 163 indexed citations
13.
Walsh, Patrick, Devon K. Taylor, & Laurence A. Turka. (2004). Tregs and transplantation tolerance. Journal of Clinical Investigation. 114(10). 1398–1403. 156 indexed citations
14.
Taylor, Devon K., David C. Neujahr, & Laurence A. Turka. (2004). Heterologous immunity and homeostatic proliferation as barriers to tolerance. Current Opinion in Immunology. 16(5). 558–564. 70 indexed citations
15.
Sundar, Krishnan, et al.. (2004). Expression of the Epstein-Barr virus nuclear antigen-1 (EBNA-1) in the mouse can elicit the production of anti-dsDNA and anti-Sm antibodies. Journal of Autoimmunity. 23(2). 127–140. 86 indexed citations
16.
Taylor, Devon K., et al.. (2002). Persistence of partially functional double-stranded (ds) DNA binding B cells in mice transgenic for the IgM heavy chain of an anti-dsDNA antibody. International Immunology. 14(1). 45–54. 10 indexed citations
17.
Taylor, Devon K., David A. Rasko, Richard Sherburne, Chien Ho, & Lawrence D. Jewell. (1998). Lack of correlation between Lewis antigen expression by and gastric epithelial cells in infected patients. Gastroenterology. 115(5). 1113–1122. 65 indexed citations
18.
Taylor, Devon K., et al.. (1998). Failure of antigen-specific immune tolerance in recurrent spontaneous aborters. Journal of the Society for Gynecologic Investigation. 5(1). 53A–53A. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erik H. Rozemuller Breakdown of academic impact, for papers by Richard Batchelor Breakdown of academic impact, for papers by Eduard Palou Breakdown of academic impact, for papers by A Svejgaard Breakdown of academic impact, for papers by Laure Bourdery Breakdown of academic impact, for papers by Dário Ligeiro Breakdown of academic impact, for papers by R Storb Breakdown of academic impact, for papers by R.F. Schipper Breakdown of academic impact, for papers by Nathalie Brassard Breakdown of academic impact, for papers by Giuliana Cassese
Rankless by CCL
2026